AF
HZNP

Allworth Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Allworth Financial’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-673
Closed -$77.9K – 3692
2023
Q3 		$77.9K Hold
673
– – ﹤0.01% 969
2023
Q2 		$69.2K Hold
673
– – ﹤0.01% 1019
2023
Q1 		$73.5K Hold
673
– – ﹤0.01% 950
2022
Q4 		$76.6K Buy
673
+51
+8% +$4.24K ﹤0.01% 886
2022
Q3 		$38K Buy
622
+562
+937% +$39.3K ﹤0.01% 1060
2022
Q2 		$5K Buy
60
+33
+122% +$3.13K ﹤0.01% 1783
2022
Q1 		$3K Sell
27
-1
-4% -$97 ﹤0.01% 1764
2021
Q4 		$3K Sell
28
-97
-78% -$10.6K ﹤0.01% 1697
2021
Q3 		$14K Buy
+125
New +$13K ﹤0.01% 1165

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Allworth Financial's HZNP Position: Q4 2023 in Review

Allworth Financial sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 673 shares — an estimated $77.9K sold.

Allworth Financial first reported a position in HZNP in Q3 2021 and held it in 9 quarters. The position peaked at $77.9K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Allworth Financial reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Allworth Financial sold 673 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $77.9K.
  • Allworth Financial first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2021 and held it in 9 quarters.
  • Allworth Financial's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $77.9K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Allworth Financial's 13F filing for Q4 2023, filed 24 Jan 2024.